{
  "trial_id": "NCT00851903",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race/ethnicity, baseline HbA1c, duration of diabetes, body mass index (BMI), fasting plasma glucose, prior diabetes treatment, serum creatinine, alanine aminotransferase (ALT), aspartate aminotransferase (AST), history of retinopathy, history of pancreatitis, alcohol or drug use history, compliance with metformin dose, ability to perform plasma blood glucose monitoring.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c)",
          "baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "fasting plasma glucose"
        ],
        [
          "Duration of diabetes",
          "duration of diabetes"
        ],
        [
          "Impaired renal function: serum creatinine",
          "serum creatinine"
        ],
        [
          "Impaired hepatic function: alanine aminotransferase (ALT)",
          "alanine aminotransferase (ALT)"
        ],
        [
          "Impaired hepatic function: aspartate aminotransferase (AST)",
          "aspartate aminotransferase (AST)"
        ],
        [
          "Active proliferative retinopathy",
          "history of retinopathy"
        ],
        [
          "History of pancreatitis",
          "history of pancreatitis"
        ],
        [
          "Alcohol or drug abuse within the last year",
          "alcohol or drug use history"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Body Weight",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Heart Rate",
        "At least one diabetic late complication",
        "Self-Monitored Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Age",
        "race/ethnicity",
        "prior diabetes treatment",
        "compliance with metformin dose",
        "ability to perform plasma blood glucose monitoring."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline HbA1c, Fasting Plasma Glucose, 7-point Glucose Profile, Body Weight, Hypoglycemia Occurrence, Duration of Diabetes, Metformin Dose,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Weight",
          "Body Weight"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "Fasting Plasma Glucose"
        ],
        [
          "Duration of diabetes",
          "Duration of Diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Heart Rate",
        "At least one diabetic late complication",
        "Self-Monitored Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Age",
        "Race/Ethnicity",
        "Region of Enrollment",
        "7-point Glucose Profile",
        "Hypoglycemia Occurrence",
        "Metformin Dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes Duration, HbA1c, Fasting Plasma Glucose, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, History of Hypertension, History of Hyperlipidemia, History of Cardiovascular Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Body Mass Index",
          "Body Mass Index"
        ],
        [
          "Systolic Blood Pressure",
          "Systolic Blood Pressure"
        ],
        [
          "Diastolic Blood Pressure",
          "Diastolic Blood Pressure"
        ],
        [
          "Duration of diabetes",
          "Diabetes Duration"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c)",
          "HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "Fasting Plasma Glucose"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight",
        "Heart Rate",
        "At least one diabetic late complication",
        "Self-Monitored Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Age",
        "Region of Enrollment",
        "History of Hypertension",
        "History of Hyperlipidemia",
        "History of Cardiovascular Disease"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at baseline, fasting plasma glucose at baseline, systolic and diastolic blood pressure, heart rate, waist circumference, smoking status, medical history (including history of hypertension, dyslipidemia, cardiovascular disease), concomitant medications, metformin dose at baseline, sitagliptin dose at baseline, insulin glargine dose at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "Systolic Blood Pressure",
          "systolic and diastolic blood pressure"
        ],
        [
          "Diastolic Blood Pressure",
          "systolic and diastolic blood pressure"
        ],
        [
          "Heart Rate",
          "heart rate"
        ],
        [
          "Duration of diabetes",
          "duration of type 2 diabetes"
        ],
        [
          "Glycosylated Hemoglobin A1c (HbA1c)",
          "HbA1c at baseline"
        ],
        [
          "Fasting Plasma Glucose",
          "fasting plasma glucose at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Body Weight",
        "At least one diabetic late complication",
        "Self-Monitored Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Age",
        "race",
        "ethnicity",
        "waist circumference",
        "smoking status",
        "medical history (including history of hypertension, dyslipidemia, cardiovascular disease)",
        "concomitant medications",
        "metformin dose at baseline",
        "sitagliptin dose at baseline",
        "insulin glargine dose at baseline"
      ]
    }
  }
}